Evaluation of small airway function and its application in patients with chronic obstructive pulmonary disease (Review)
- Authors:
- Yan Li
- Xin-Yang Li
- Li-Rong Yuan
- Hai-Long Wang
- Min Pang
-
Affiliations: Department of Pulmonary and Critical Care Medicine, The First Hospital, Shanxi Medical University, Taiyuan, Shanxi 030001, P.R. China, Department of Medical Parasitology, School of Basic Medicine, Basic Medical Science Center, Shanxi Medical University, Jinzhong, Shanxi 030600, P.R. China - Published online on: September 29, 2021 https://doi.org/10.3892/etm.2021.10822
- Article Number: 1386
This article is mentioned in:
Abstract
|
López-Campos JL, Tan W and Soriano JB: Global burden of COPD. Respirology. 21:14–23. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Crisafulli E, Pisi R, Aiello M, Vigna M, Tzani P, Torres A, Bertorelli G and Chetta A: Prevalence of small-airway dysfunction among COPD patients with different GOLD stages and its role in the impact of disease. Respiration. 93:32–41. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hogg JC, Pare PD and Hackett TL: The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease. Physiol Rev. 97:529–552. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Barnes PJ: Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 138:16–27. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Higham A, Quinn AM, Cancado JED and Singh D: The pathology of small airways disease in COPD: Historical aspects and future directions. Respir Res. 20(49)2019.PubMed/NCBI View Article : Google Scholar | |
|
Day K, Ostridge K, Conway J, Cellura D, Watson A, Spalluto CM, Staples KJ, Thompson B and Wilkinson T: Interrelationships among small airways dysfunction, neutrophilic inflammation, and exacerbation frequency in COPD. Chest. 159:1391–1399. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, Hallstrand TS, Kaminsky DA, McCarthy K, McCormack MC, et al: Standardization of spirometry 2019 update. An official american thoracic society and european respiratory society technical statement. Am J Respir Crit Care Med. 200:e70–e88. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Morris ZQ, Coz A and Starosta D: An isolated reduction of the FEV3/FVC ratio is an indicator of mild lung injury. Chest. 144:1117–1123. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Borekci S, Demir T, Gorek Dilektasli A, Uygun M and Yildirim N: A simple measure to assess hyperinflation and air trapping: 1-Forced expiratory volume in three second/forced vital capacity. Balkan Med J. 34:113–118. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Dilektasli AG, Porszasz J, Casaburi R, Stringer WW, Bhatt SP, Pak Y, Rossiter HB, Washko G, Castaldi PJ, Estepar RSJ, et al: A novel spirometric measure identifies mild COPD unidentified by standard criteria. Chest. 150:1080–1090. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Saint-Pierre M, Ladha J, Berton DC, Reimao G, Castelli G, Marillier M, Bernard AC, O'Donnell DE and Neder JA: Is the slow vital capacity clinically useful to uncover airflow limitation in subjects with preserved FEV1/FVC ratio? Chest. 156:497–506. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Wu J, Lu AD, Zhang LP, Zuo YX and Jia YP: Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia. Zhonghua Xue Ye Xue Za Zhi. 40:52–57. 2019.PubMed/NCBI View Article : Google Scholar : (In Chinese). | |
|
Li K, Gao Y, Pan Z, Jia X, Yan Y, Min X, Huang K and Jiang T: Influence of emphysema and air trapping heterogeneity on pulmonary function in patients with COPD. Int J Chron Obstruct Pulmon Dis. 14:2863–2872. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Chiu HY, Hsiao YH, Su KC, Lee YC, Ko HK and Perng DW: Small airway dysfunction by impulse oscillometry in symptomatic patients with preserved pulmonary function. J Allergy Clin Immunol Practe. 8:229–235.e3. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Su ZQ, Guan WJ, Li SY, Ding M, Chen Y, Jiang M, Chen XB, Zhong CH, Tang CL and Zhong NS: Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD. Int J Chron Obstruct Pulmon Dis. 13:3031–3044. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Desai U and Joshi JM: Impulse oscillometry. Adv Respir Med. 87:235–238. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Kanazawa H, Tochino Y, Kyoh S, Ichimaru Y, Asai K and Hirata K: Potential roles of pentosidine in age-related and disease-related impairment of pulmonary functions in patients with asthma. J Allergy Clin Immunol. 127:899–904. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Boeck L, Gensmer A, Nyilas S, Stieltjes B, Re TJ, Tamm M, Latzin P and Stolz D: Single-breath washout tests to assess small airway disease in COPD. Chest. 150:1091–1100. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Bell AS, Lawrence PJ, Singh D and Horsley A: Feasibility and challenges of using multiple breath washout in COPD. Int J Chron Obstruct Pulmon Dis. 13:2113–2119. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Jetmalani K, Thamrin C, Farah CS, Bertolin A, Chapman DG, Berend N, Salome CM and King GG: Peripheral airway dysfunction and relationship with symptoms in smokers with preserved spirometry. Respirology. 23:512–518. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Liu B, Zhou Q and He B: The application of multiple breath nitrogen washout in chronic obstructive pulmonary disease. Zhonghua Jie He He Hu Xi Za Zhi. 38:492–496. 2015.PubMed/NCBI(In Chinese). | |
|
Criner RN, Hatt CR, Galban CJ, Kazerooni EA, Lynch DA, McCormack MC, Casaburi R, MacIntyre NR, Make BJ, Martinez FJ, et al: Relationship between diffusion capacity and small airway abnormality in COPDGene. Respir Res. 20(269)2019.PubMed/NCBI View Article : Google Scholar | |
|
Wang JY, Suddards ME, Mellor CJ and Owers-Bradley JR: Lung function measurement with multiple-breath-helium washout system. Med Eng Phys. 35:457–469. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Port J, Tao Z, Junger A, Joppek C, Tempel P, Husemann K, Singer F, Latzin P, Yammine S, Nagel JH and Kohlhäufl M: A simple method to reconstruct the molar mass signal of respiratory gas to assess small airways with a double-tracer gas single-breath washout. Med Biol Eng Comput. 55:1975–1987. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hirano T, Matsunaga K, Sugiura H, Minakata Y, Koarai A, Akamatsu K, Ichikawa T, Furukawa K and Ichinose M: Relationship between alveolar nitric oxide concentration in exhaled air and small airway function in COPD. J Breath Res. 7(046002)2013.PubMed/NCBI View Article : Google Scholar | |
|
Santus P, Radovanovic D, Mascetti S, Pauletti A, Valenti V, Mantero M, Papi A and Contoli M: Effects of bronchodilation on biomarkers of peripheral airway inflammation in COPD. Pharmacoll Res. 133:160–169. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Hersh CP, Washko GR, Estépar RS, Lutz S, Friedman PJ, Han MK, Hokanson JE, Judy PF, Lynch DA, Make BJ, et al: Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res. 14(42)2013.PubMed/NCBI View Article : Google Scholar | |
|
Timmins SC, Diba C, Farrow CE, Schoeffel RE, Berend N, Salome CM and King GG: The relationship between airflow obstruction, emphysema extent, and small airways function in COPD. Chest. 142:312–319. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Vasilescu DM, Martinez FJ, Marchetti N, Galbán CJ, Hatt C, Meldrum CA, Dass C, Tanabe N, Reddy RM, Lagstein A, et al: Noninvasive imaging biomarker identifies small airway damage in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 200:575–581. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Tanabe N, Shima H, Sato S, Oguma T, Kubo T, Kozawa S, Koizumi K, Sato A, Togashi K and Hirai T: Direct evaluation of peripheral airways using ultra-high-resolution CT in chronic obstructive pulmonary disease. Eur J Radiol. 120(108687)2019.PubMed/NCBI View Article : Google Scholar | |
|
Pike D, Kirby M, Guo F, McCormack DG and Parraga G: Ventilation heterogeneity in ex-smokers without airflow limitation. Acad Radiol. 22:1068–1078. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Stavngaard T, Sogaard LV, Mortensen J, Hanson LG, Schmiedeskamp J, Berthelsen AK and Dirksen A: Hyperpolarized 3He MRI and 81mKr SPECT in chronic obstructive pulmonary disease. Eur J Nucl Med Mol Imaging. 32:448–457. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Capaldi DP, Zha N, Guo F, Pike D, McCormack DG, Kirby M and Parraga G: Pulmonary imaging biomarkers of gas trapping and emphysema in COPD: (3)He MR imaging and CT parametric response maps. Radiology. 279:597–608. 2016.PubMed/NCBI View Article : Google Scholar | |
|
van Beek EJ, Dahmen AM, Stavngaard T, Gast KK, Heussel CP, Krummenauer F, Schmiedeskamp J, Wild JM, Søgaard LV, Morbach AE, et al: Hyperpolarised 3He MRI versus HRCT in COPD and normal volunteers: PHIL trial. Eur Respir J. 34:1311–1321. 2009.PubMed/NCBI View Article : Google Scholar | |
|
MacNeil JL, Capaldi DPI, Westcott AR, Eddy RL, Barker AL, McCormack DG, Kirby M and Parraga G: Pulmonary imaging phenotypes of chronic obstructive pulmonary disease using multiparametric response maps. Radiology. 295:227–236. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Kirby M, Svenningsen S, Owrangi A, Wheatley A, Farag A, Ouriadov A, Santyr GE, Etemad-Rezai R, Coxson HO, McCormack DG and Parraga G: Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology. 265:600–610. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Yokoe K, Satoh K, Yamamoto Y, Nishiyama Y, Asakura H, Haba R and Ohkawa M: Usefulness of 99mTc-Technegas and 133Xe dynamic SPECT in ventilatory impairment. Nucl Medi Commun. 27:887–892. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y, Ding M, Guan WJ, Wang W, Luo WZ, Zhong CH, Jiang M, Jiang JH, Gu YY, Li SY and Zhong NS: Validation of human small airway measurements using endobronchial optical coherence tomography. Respir Med. 109:1446–1453. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Braido F, Riccio AM, Guerra L, Gamalero C, Zolezzi A, Tarantini F, De Giovanni B, Folli C, Descalzi D and Canonica GW: Clara cell 16 protein in COPD sputum: A marker of small airways damage? Respir Med. 101:2119–2124. 2007.PubMed/NCBI View Article : Google Scholar | |
|
Hao W, Li M, Pang Y, Du W and Huang X: Increased chemokines levels in patients with chronic obstructive pulmonary disease: Correlation with quantitative computed tomography metrics. Br J Radiol. 94(20201030)2021.PubMed/NCBI View Article : Google Scholar | |
|
Wang H, Yang T, Li D, Wu Y, Zhang X, Pang C, Zhang J, Ying B, Wang T and Wen F: Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 11:2369–2376. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Kawamoto T, Kanazawa H, Tochino Y and Kawaguchi T: Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease. Respir Med. 141:159–164. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Ostridge K, Williams N, Kim V, Bennett M, Harden S, Welch L, Bourne S, Coombs NA, Elkington PT, Staples KJ and Wilkinson TM: Relationship between pulmonary matrix metalloproteinases and quantitative CT markers of small airways disease and emphysema in COPD. Thorax. 71:126–132. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Gupta N, Malhotra N and Ish P: GOLD 2021 guidelines for COPD-what's new and why. Adv Respir Med. 89:344–346. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Maltais F, Bjermer L, Kerwin EM, Jones PW, Watkins ML, Tombs L, Naya IP, Boucot IH, Lipson DA, Compton C, et al: Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: The EMAX randomised trial. Respir Res. 20(238)2019.PubMed/NCBI View Article : Google Scholar | |
|
Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, et al: Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 378:1671–1680. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, et al: Triple inhaled therapy at two glucocorticoid doses in Moderate-to-Very-Severe COPD. N Engl J Med. 383:35–48. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Gupta N, Agrawal S, Chakrabarti S and Ish P: COPD 2020 Guidelines-what is new and why? Adv Respir Med. 88:38–40. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, Camargo CA, Griffiths CJ, Janssens W and Martineau AR: Vitamin D to prevent exacerbations of COPD: Systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 74:337–345. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Alavi Foumani A, Mehrdad M, Jafarinezhad A, Nokani K and Jafari A: Impact of vitamin D on spirometry findings and quality of life in patients with chronic obstructive pulmonary disease: A randomized, double-blinded, placebo-controlled clinical trial. Int J Chron Obstruct Pulmon Dis. 14:1495–1501. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Criner GJ, Delage A, Voelker K, Hogarth DK, Majid A, Zgoda M, Lazarus DR, Casal R, Benzaquen SB, Holladay RC, et al: Improving lung function in severe heterogenous emphysema with the spiration valve system (EMPROVE). A multicenter, open-label randomized controlled clinical trial. Am J Respir Crit Care Med. 200:1354–1362. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Santus P, Radovanovic D, Pecchiari M, Ferrando M, Tursi F, Patella V and Braido F: The Relevance of targeting treatment to small airways in asthma and COPD. Respir Care. 65:1392–1412. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Lavorini F, Pedersen S and Usmani OS: Dilemmas, confusion, and misconceptions related to small airways directed therapy. Chest. 151:1345–1355. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Usmani OS, Mignot B, Kendall I, Maria R, Cocconi D, Georges G and Scichilone N: Predicting lung deposition of extrafine inhaled corticosteroid-containing fixed combinations in patients with chronic obstructive pulmonary disease using functional respiratory imaging: An in silico study. J Aerosol Med Pulm Drug Deliv. 34:204–211. 2020.PubMed/NCBI View Article : Google Scholar |
